Hip Arthropathy — Subsidence of Cementless Stem Following Arthroplasty for Fracture Neck of Femur
Citation(s)
Al-Najjim M, Khattak U, Sim J, Chambers I Differences in subsidence rate between alternative designs of a commonly used uncemented femoral stem. J Orthop. 2016 Jul 5;13(4):322-6. doi: 10.1016/j.jor.2016.06.026. eCollection 2016 Dec.
Guyen O Hemiarthroplasty or total hip arthroplasty in recent femoral neck fractures? Orthop Traumatol Surg Res. 2019 Feb;105(1S):S95-S101. doi: 10.1016/j.otsr.2018.04.034. Epub 2018 Nov 16.
Leiss F, Gotz JS, Meyer M, Maderbacher G, Reinhard J, Parik L, Grifka J, Greimel F Differences in femoral component subsidence rate after THA using an uncemented collarless femoral stem: full weight-bearing with an enhanced recovery rehabilitation versus partial weight-bearing. Arch Orthop Trauma Surg. 2022 Apr;142(4):673-680. doi: 10.1007/s00402-021-03913-0. Epub 2021 May 21.
Parvizi J, Keisu KS, Hozack WJ, Sharkey PF, Rothman RH Primary total hip arthroplasty with an uncemented femoral component: a long-term study of the Taperloc stem. J Arthroplasty. 2004 Feb;19(2):151-6. doi: 10.1016/j.arth.2003.10.003.
Ries C, Boese CK, Dietrich F, Miehlke W, Heisel C Femoral stem subsidence in cementless total hip arthroplasty: a retrospective single-centre study. Int Orthop. 2019 Feb;43(2):307-314. doi: 10.1007/s00264-018-4020-x. Epub 2018 Jun 18.
Subsidence of Cementless Stem Following Arthroplasty for Fracture Neck of Femur
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
